Atlas Trials

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Clinical trial NCT05210374 · RECRUITING

Trial details

NCT number
NCT05210374
Sponsor
Case Comprehensive Cancer Center
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed Sarcomas
Start date
2023-03-09
Primary completion
2026-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.